Lupin Pursues India Approval For Lucentis Biosimilar, COVID-19 Opportunities

Favors Voluntary Licensing

 
• By Vibha Ravi
  
Lab Instruments
Lupin Seeks Approval For Lucentis Biosimilar In India As It Expands Product Pipeline • Source: Alamy

More from Strategy

More from Business